Affordable Access

Publisher Website

Synthesis, characterization and in vitro biological evaluation of [Ru(η6-arene)(N,N)Cl]PF6 compounds using the natural products arenes methylisoeugenol and anethole

Authors
Journal
Journal of Organometallic Chemistry
0022-328X
Publisher
Elsevier
Identifiers
DOI: 10.1016/j.jorganchem.2014.09.005
Keywords
  • Bioorganometallic
  • Ru(Ii) Complexes
  • Natural Products
  • Cytotoxicity
Disciplines
  • Biology

Abstract

Abstract Five new organometallic Ru(II) compounds (VI−X) with the general formula [Ru(η6-arene)(N,N)Cl]PF6, where arene-N,N correspond to methylisoeugenol-bipyridine (VI); anethole-bipyridine (VII); methylisoeugenol-ethylenediamine (VIII); anethole-ethylenediamine (IX) and methylisoeugenol-1,2-diaminobenzene (X), have been synthesized, fully characterized and biologically evaluated in vitro. The reaction conditions based on the reduction of [Ru(1,5-COD)Cl2]nin situ with methyleugenol and estragole, which are natural ligands, induced an alkene isomerization on the allylic substituent of coordinated arenes. The Ru(II)-arene bond formation and isomerization of the CC bond on the allyl substituent was confirmed using 1H NMR spectroscopy; this result was validated for compound VIII by X-ray diffraction. An XRD analysis revealed the presence of both enantiomers of the complex in the single-crystal. Compounds IX and X exhibited a better cytotoxic activity in vitro than carboplatin, which is a commercial drug, against three human tumor cell lines (MCF-7, PC-3 and HT-29).

There are no comments yet on this publication. Be the first to share your thoughts.